Policy changes Backwork has recorded, newest first. The most recent change on record is from October 24, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
86,510 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Pegfilgrastim (Neulasta); Pegfilgrastim-jmdb (Fulphila); Pegfilgrastim--pbbk (Fylnetra); Pegfilgrastim- apgf (Nyvepria); Pegfilgrastim-fpgk (Stimufed); Pegfilgrastim-cbqv (Udenyca); Pegfilgrastim-bmez (Ziextenzo) | Metadata changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Noninvasive Imaging Techniques for Evaluation and Monitoring of Chronic Liver Diseases | Codes changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Noninvasive Imaging Techniques for Evaluation and Monitoring of Chronic Liver Diseases | Metadata changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Nivolumab/Relatlimab-rmbw (Opdualag) | Metadata changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Negative Pressure Wound Therapy in the Outpatient Setting | Metadata changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Nedosiran (Rivfloza) | Metadata changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Natalizumab (Tysabri), Natalizumab-sztn (Tyruko) | Metadata changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Microprocessor-Controlled Prostheses for the Lower Limb | Metadata changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Methoxy Polyethylene Glycol-Epoetin Beta (Mircera) | Metadata changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Vestronidase Alfa-vjbk(Mepsevii) | Metadata changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Mastectomy for Gynecomastia | Metadata changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | FDA-Approved Indications | Metadata changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Voretigene Neparvovec-rzyl (Luxturna) | Metadata changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Luspatercept-aamt (Reblozyl) | Metadata changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Mosunetuzumab-axgb (Lunsumio, Lunsumio Velo) | Metadata changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Lovotibeglogene Autotemcel (Lyfgenia) | Metadata changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Pegzilarginase-nbln (Loargys) | New policy |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Laser Assisted Uvulopalatoplasty (LAUP) | Metadata changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Lanreotide (Somatuline Depot; Lanreotide*) | Metadata changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Velmanase Alfa-tycv (Lamzede) | Metadata changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Pegloticase (Krystexxa) | Metadata changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Tebentafusp-tebn (Kimmtrak) | Metadata changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Pembrolizumab (Keytruda) | Metadata changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Onasemnogene Abeparvovec-brve (Itvisma) | New policy |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Isatuximab-irfc (Sarclisa) | Metadata changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Irinotecan Liposome Injection (Onivyde) | Metadata changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Intraoperative Radiation Therapy (IORT) | Metadata changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Inotersen (Tegsedi) | Metadata changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Inebilizumab-cdon (Uplizna) | Metadata changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Inclisiran (Leqvio) | Metadata changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Talimogene Laherparepvec (Imlygic) | Metadata changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Image-Guided Minimally Invasive Decompression for Spinal Stenosis | Metadata changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Travoprost Intracameral Implant (iDose TR) | Metadata changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Histrelin Acetate (Supprelin LA) | Metadata changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Trastuzumab Products (Herceptin, Ontruzant, Herzuma, Ogivri, Trazimera, Kanjinti, Hercessi) | Metadata changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Trastuzumab and Hyaluronidase-oysk (Herceptin Hylecta) | Metadata changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Givosiran (Givlaari) | Metadata changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Genetic Testing for Mental Health Conditions | Metadata changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Gemtuzumab Ozogamicin (Mylotarg) | Metadata changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Sirolimus protein-bound particles for injectable suspension (albumin-bound) (Fyarro) | Metadata changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Fosdenopterin (Nulibry) | Metadata changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Fluocinolone Acetonide Implant (Yutiq) | Metadata changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Fluocinolone Acetonide Implant (Retisert) | Metadata changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Fluocinolone Acetonide Implant (Iluvien) | Metadata changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Evinacumab-dgnb (Evkeeza) | Metadata changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Romosozumab-aqqg (Evenity) | Metadata changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Etranacogene Dezaparvovec-drlb (Hemgenix) | Metadata changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Epoetin Alfa Products(Epogen, Procrit, Retacrit) | Metadata changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Fam-trastuzumab Deruxtecan-nxki (Enhertu) | Metadata changed |
| Aug 1, 2026 | BlueCross BlueShield of Tennessee | Enfortumab Vedotin-ejfv (Padcev) | Metadata changed |